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Introduction
Serum biomarkers of bone and cartilage turnover were
found to predict structural damage progression in
Rheumatoid Arthritis (RA). Their potential value in
Juvenile Idiopathic Arthritis (JIA) has never been
explored.
Objectives
1) To examine associations between soluble biomarkers of
bone (CTX-I) and cartilage degradation (C1-2C, C2C) and
joint damage as assessed by Conventional Radiography
(CR) and Magnetic Resonance Imaging (MRI) in patients
with JIA. 2) To investigate whether these biomarkers can
predict structural damage progression.
Methods
The clinically more affected wrist of 88 JIA patients was
studied with CR according to adapted Sharp/van der
Heijde score (SHS) method and MRI by using the OMER-
ACT RA-MRI-score, coupled with standard clinical assess-
ment. One-year CR follow-up was available in 65 patients,
whereas one-year MRI follow-up was available in
51 patients. Serum CTX-I, C1-2C, C2C were measured by
ELISA assays in all patients at the enrollment and in
gender- and age-matched healthy controls (N= 154).
Results
Unlike adults with RA, CTX-I, C1,2C and C2C levels
were significantly lower in JIA patients than healthy
controls (P< 0.0001).
Biomarker levels did not correlate with clinical mea-
sure of disease activity and damage, disease duration
and with Sharp/van der Heijde score (SHS), and RAM-
RIS bone erosion score.Median C1,2C and C2C were
significantly higher in patients with structural damage
progression according to JSN (joint space narrowing)-
SHS score compared to patients without progression
(C1,2C: 240 ng/ml vs 125 ng/ml, P=0.01; C2C:
133.7 ng/ml vs 65.7 ng/ml, P=0.001). Unlike RA,
patients with radiographic progression showed signifi-
cantly lower levels of CTX-I (1.03 ng/ml) compared
patients without structural damage progression
(1.53 mg/ml P=0.03).Patients, who required either
initiation of methotrexate or addition of a biologic
agent at the 6 months follow-up visit, had significantly
higher levels of C1,2C (P=0.027) and C2C (P=0.034)
compared to patients who did not require treatment
changes.
Conclusion
Our results suggest an inhibition of bone and cartilage
turnover in patients with JIA. Biomarkers of cartilage
degradation are promising as potential predictors of struc-
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